Mon, Sep. 30, 6 PM (CET) |60 min| FREE Joberty Online WebinarBuilding an Open Source Q&A System with Referenced and Verifiable Answers
In this talk, we will present the VerifAI system, developed with the Institute of Artificial Intelligence Research and Development of Serbia and Bayer, and funded by Horizon Europe’s Next Generation Internet Search
VerifAI is a biomedical question-answering system that provides verified answers from scientific literature and is designed to combat hallucinations.
0 seats left
You’ll learn about the challenges faced and the solutions implemented during the development of this system, which could offer valuable insights and strategies for your own projects.
The webinar will be conducted in English.
100+ have signed up
In this presentation, you will learn why:
Hallucinations are especially challenge for science-based systems.
RAG can reduce hallucinations but does not totally eliminate it.
Additional mechanisms are needed to fully combat GenAI hallucinations.
Nikola Milošević, our speaker
Nikola has about 15 years of professional experience in artificial intelligence and natural language processing.
He graduated from the Faculty of Electrical Engineering, University of Belgrade, and obtained PhD in Computer Science from the University of Manchester.
Currently, he is working in Bayer Pharma R&D as a science fellow.
Making tech scene more transperent
It’s our job to do it.
100.000+ IT professionals
Join a workplace community platform. Anonymously share your experience, start discussions and apply for jobs.
Transparency
Search for tech jobs and get relevant information about employers. Explore 20.000+ employer reviews regarding company culture, salaries, benefits, teams, projects, technologies and interview process.
Perfect match
Our AI powered job matching algorithm is designed to match you with exciting job opportunities that align with your skills, experience, and career goals.
Global platform
Our fundamental purpose of exchanging insights, career opportunities, and information remains unchanged. However, the international scope of this initiative has grown!